Table of Contents Author Guidelines Submit a Manuscript
Gastroenterology Research and Practice
Volume 2016, Article ID 6718590, 6 pages
http://dx.doi.org/10.1155/2016/6718590
Research Article

Association of Tissue Transglutaminase Antibody Titer with Duodenal Histological Changes in Children with Celiac Disease

1Department of Pediatrics, Hashemite University, P.O. Box 1504514, Zarqa 13115, Jordan
2Department of Pediatrics, Prince Hamzah Hospital, P.O. Box 86, Amman 11118, Jordan
3Department of Pathology, Prince Hamzah Hospital, P.O. Box 86, Amman 11118, Jordan

Received 7 April 2016; Revised 4 July 2016; Accepted 26 July 2016

Academic Editor: David Bernardo

Copyright © 2016 Hasan Hawamdeh et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Alaedini and P. H. R. Green, “Narrative review: celiac disease: understanding a complex autoimmune disorder,” Annals of Internal Medicine, vol. 142, no. 4, pp. 289–298, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. J. F. Ludvigsson, D. A. Leffler, J. C. Bai et al., “The Oslo definitions for coeliac disease and related terms,” Gut, vol. 62, no. 1, pp. 43–52, 2013. View at Publisher · View at Google Scholar · View at Scopus
  3. M. N. Marsh, “Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity (‘celiac sprue’),” Gastroenterology, vol. 102, no. 1, pp. 330–354, 1992. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Biagi, C. Klersy, D. Balduzzi, and G. R. Corazza, “Are we not over-estimating the prevalence of coeliac disease in the general population?” Annals of Medicine, vol. 42, no. 8, pp. 557–561, 2010. View at Publisher · View at Google Scholar · View at Scopus
  5. A. Fasano, I. Berti, T. Gerarduzzi et al., “Prevalence of Celiac disease in at-risk and not-at-risk groups in the United States: a large multicenter study,” Archives of Internal Medicine, vol. 163, no. 3, pp. 286–292, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. P. H. R. Green, S. N. Stavropoulos, S. G. Panagi et al., “Characteristics of adult celiac disease in the USA: results of a national survey,” The American Journal of Gastroenterology, vol. 96, no. 1, pp. 126–131, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. P. H. Green and C. Cellier, “Celiac disease,” The New England Journal of Medicine, vol. 357, no. 17, pp. 1731–1743, 2007. View at Publisher · View at Google Scholar
  8. C. Ciacci, M. Cirillo, R. Sollazzo, G. Savino, F. Sabbatini, and G. Mazzacca, “Gender and clinical presentation in adult celiac disease,” Scandinavian Journal of Gastroenterology, vol. 30, no. 11, pp. 1077–1081, 1995. View at Publisher · View at Google Scholar · View at Scopus
  9. L. M. Sollid, G. Markussen, J. Ek, H. Gjerde, F. Vartdal, and E. Thorsby, “Evidence for a primary association of celiac disease to a particular HLA-DQ α/β heterodimer,” The Journal of Experimental Medicine, vol. 169, no. 1, pp. 345–350, 1989. View at Publisher · View at Google Scholar · View at Scopus
  10. L. M. Sollid and E. Thorsby, “The primary association of celiac disease to a given HLA-DQ α/β heterodimer explains the divergent HLA-DR associations observed in various Caucasian populations,” Tissue Antigens, vol. 36, no. 3, pp. 136–137, 1990. View at Publisher · View at Google Scholar · View at Scopus
  11. M. Caproni, E. Antiga, L. Melani, and P. Fabbri, “Guidelines for the diagnosis and treatment of dermatitis herpetiformis,” Journal of the European Academy of Dermatology and Venereology, vol. 23, no. 6, pp. 633–638, 2009. View at Publisher · View at Google Scholar · View at Scopus
  12. D. Bai, P. Brar, S. Holleran, R. Ramakrishnan, and P. H. R. Green, “Effect of gender on the manifestations of celiac disease: evidence for greater malabsorption in men,” Scandinavian Journal of Gastroenterology, vol. 40, no. 2, pp. 183–187, 2005. View at Publisher · View at Google Scholar · View at Scopus
  13. A. R. Frost, M. M. Band, and G. S. Conway, “Serological screening for coeliac disease in adults with Turner's syndrome: prevalence and clinical significance of endomysium antibody positivity,” European Journal of Endocrinology, vol. 160, no. 4, pp. 675–679, 2009. View at Publisher · View at Google Scholar · View at Scopus
  14. A. Lenhardt, A. Plebani, F. Marchetti et al., “Role of human-tissue transglutaminase IgG and anti-gliadin IgG antibodies in the diagnosis of coeliac disease in patients with selective immunoglobulin A deficiency,” Digestive and Liver Disease, vol. 36, no. 11, pp. 730–734, 2004. View at Publisher · View at Google Scholar · View at Scopus
  15. A. Rubio-Tapia, C. T. Van Dyke, B. D. Lahr et al., “Predictors of family risk for celiac disease: a population-based study,” Clinical Gastroenterology and Hepatology, vol. 6, no. 9, pp. 983–987, 2008. View at Publisher · View at Google Scholar
  16. C. Sategna Guidetti, E. Solerio, N. Scaglione, G. Aimo, and G. Mengozzi, “Duration of gluten exposure in adult coeliac disease does not correlate with the risk for autoimmune disorders,” Gut, vol. 49, no. 4, pp. 502–505, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. N. Sattar, F. Lazare, M. Kacer et al., “Celiac disease in children, adolescents, and young adults with autoimmune thyroid disease,” The Journal of Pediatrics, vol. 158, no. 2, pp. 272–275.e1, 2011. View at Publisher · View at Google Scholar · View at Scopus
  18. A. Ventura, G. Magazzu, and L. Greco, “Duration of exposure to gluten and risk for autoimmune disorders in patients with celiac disease,” Gastroenterology, vol. 117, no. 2, pp. 297–303, 1999. View at Publisher · View at Google Scholar · View at Scopus
  19. U. Volta, F. Tovoli, and G. Caio, “Clinical and immunological features of celiac disease in patients with Type 1 diabetes mellitus,” Expert Review of Gastroenterology and Hepatology, vol. 5, no. 4, pp. 479–487, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Wouters, M. E. Weijerman, A. M. van Furth et al., “Prospective human leukocyte antigen, endomysium immunoglobulin a antibodies, and transglutaminase antibodies testing for celiac disease in children with Down syndrome,” Journal of Pediatrics, vol. 154, no. 2, pp. 239–242, 2009. View at Publisher · View at Google Scholar · View at Scopus
  21. N. R. Lewis and B. B. Scott, “Meta-analysis: deamidated gliadin peptide antibody and tissue transglutaminase antibody compared as screening tests for coeliac disease,” Alimentary Pharmacology and Therapeutics, vol. 31, no. 1, pp. 73–81, 2010. View at Publisher · View at Google Scholar · View at Scopus
  22. A. Rostom, C. Dubé, A. Cranney et al., “The diagnostic accuracy of serologic tests for celiac disease: a systematic review,” Gastroenterology, vol. 128, no. 4, pp. S38–S46, 2005. View at Publisher · View at Google Scholar · View at Scopus
  23. F. Bao, P. H. R. Green, and G. Bhagat, “An update on celiac disease histopathology and the road ahead,” Archives of Pathology & Laboratory Medicine, vol. 136, no. 7, pp. 735–745, 2012. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Bonamico, P. Mariani, E. Thanasi et al., “Patchy villous atrophy of the duodenum in childhood celiac disease,” Journal of Pediatric Gastroenterology & Nutrition, vol. 38, no. 2, pp. 204–207, 2004. View at Publisher · View at Google Scholar · View at Scopus
  25. A. Fasano and C. Catassi, “Celiac disease,” The New England Journal of Medicine, vol. 367, no. 25, pp. 2419–2426, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. M. R. Donaldson, L. S. Book, K. M. Leiferman, J. J. Zone, and S. L. Neuhausen, “Strongly positive tissue transglutaminase antibodies are associated with Marsh 3 histopathology in adult and pediatric celiac disease,” Journal of Clinical Gastroenterology, vol. 42, no. 3, pp. 256–260, 2008. View at Publisher · View at Google Scholar · View at Scopus
  27. A. Rahmati, R. Shakeri, M. Sohrabi et al., “Correlation of tissue transglutaminase antibody with duodenal histologic marsh grading,” Middle East Journal of Digestive Diseases, vol. 6, no. 3, pp. 131–136, 2014. View at Google Scholar
  28. S. Zulfaiqar, A. Fahim, A. Qureshi et al., “Celiac disease; histopathological evaluation of endoscopic duodenal biopsies in patients,” The Professional Medical Journal, vol. 22, no. 6, pp. 72–75, 2015. View at Google Scholar
  29. A. Monzani, A. Rapa, P. Fonio, E. Tognato, L. Panigati, and G. Oderda, “Use of deamidated gliadin peptide antibodies to monitor diet compliance in childhood celiac disease,” Journal of Pediatric Gastroenterology and Nutrition, vol. 53, no. 1, pp. 55–60, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. N. R. Lewis and B. B. Scott, “Systematic review: the use of serology to exclude or diagnose coeliac disease (a comparison of the endomysial and tissue transglutaminase antibody tests),” Alimentary Pharmacology & Therapeutics, vol. 24, no. 1, pp. 47–54, 2006. View at Publisher · View at Google Scholar
  31. S. Vallejo-Diez, D. Bernardo, M. L. de Moreno et al., “Detection of specific IgA antibodies against a novel deamidated 8-mer gliadin peptide in blood plasma samples from celiac patients,” PLoS ONE, vol. 8, no. 11, Article ID e80982, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. K. Giersiepen, M. Lelgemann, N. Stuhldreher et al., “Accuracy of diagnostic antibody tests for coeliac disease in children: summary of an evidence report,” Journal of Pediatric Gastroenterology and Nutrition, vol. 54, no. 2, pp. 229–241, 2012. View at Publisher · View at Google Scholar · View at Scopus
  33. S. Husby, S. Koletzko, I. R. Korponay-Szabó et al., “European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease,” Journal of Pediatric Gastroenterology & Nutrition, vol. 54, no. 1, pp. 136–160, 2012. View at Publisher · View at Google Scholar
  34. I. Dahlbom, I. R. Korponay-Szabó, J. B. Kovács, Z. Szalai, M. Mäki, and T. Hansson, “Prediction of clinical and mucosal Severity of coeliac disease and dermatitis herpetiformis by quantification of IgA/IgG serum antibodies to tissue transglutaminase,” Journal of Pediatric Gastroenterology and Nutrition, vol. 50, no. 2, pp. 140–146, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. P. G. Hill and G. K. T. Holmes, “Coeliac disease: a biopsy is not always necessary for diagnosis,” Alimentary Pharmacology and Therapeutics, vol. 27, no. 7, pp. 572–577, 2008. View at Publisher · View at Google Scholar · View at Scopus
  36. S. Vivas, J. G. Ruiz De Morales, S. Riestra et al., “Duodenal biopsy may be avoided when high transglutaminase antibody titers are present,” World Journal of Gastroenterology, vol. 15, no. 38, pp. 4775–4780, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. C. C. Barker, C. Mitton, G. Jevon, and T. Mock, “Can tissue transglutaminase antibody titers replace small-bowel biopsy to diagnose celiac disease in select pediatric populations?” Pediatrics, vol. 115, no. 5, pp. 1341–1346, 2005. View at Publisher · View at Google Scholar · View at Scopus
  38. D. Gidrewicz, K. Potter, C. L. Trevenen, M. Lyon, and J. D. Butzner, “Evaluation of the ESPGHAN celiac guidelines in a North American pediatric population,” American Journal of Gastroenterology, vol. 110, no. 5, pp. 760–767, 2015. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Bhattacharya, A. Lomash, P. Sakhuja, A. P. Dubey, and S. Kapoor, “Clinical and histopathological correlation of duodenal biopsy with IgA anti-tissue transglutaminase titers in children with celiac disease,” Indian Journal of Gastroenterology, vol. 33, no. 4, pp. 350–354, 2014. View at Publisher · View at Google Scholar · View at Scopus
  40. C. M. Trovato, M. Montuori, C. Anania et al., “Are ESPGHAN ‘biopsy-sparing’ Guidelines for celiac disease also suitable for asymptomatic patients?” American Journal of Gastroenterology, vol. 110, pp. 1485–1489, 2015. View at Publisher · View at Google Scholar · View at Scopus
  41. A. Ravelli, S. Bolognini, M. Gambarotti, and V. Villanacci, “Variability of histologic lesions in relation to biopsy site in gluten-sensitive enteropathy,” The American Journal of Gastroenterology, vol. 100, no. 1, pp. 177–185, 2005. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Ravelli, V. Villanacci, C. Monfredini, S. Martinazzi, V. Grassi, and S. Manenti, “How patchy is patchy villous atrophy?: distribution pattern of histological lesions in the duodenum of children with celiac disease,” The American Journal of Gastroenterology, vol. 105, no. 9, pp. 2103–2110, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. D. C. Weir, J. N. Glickman, T. Roiff, C. Valim, and A. M. Leichtner, “Variability of histopathological changes in childhood celiac disease,” The American Journal of Gastroenterology, vol. 105, no. 1, pp. 207–212, 2010. View at Publisher · View at Google Scholar · View at Scopus
  44. A. D. Hopper, S. S. Cross, and D. S. Sanders, “Patchy villous atrophy in adult patients with suspected gluten-sensitive enteropathy: is a multiple duodenal biopsy strategy appropriate?” Endoscopy, vol. 40, no. 3, pp. 219–224, 2008. View at Publisher · View at Google Scholar · View at Scopus
  45. H. J. Freeman, “Strongly positive tissue transglutaminase antibody assays without celiac disease,” Canadian Journal of Gastroenterology, vol. 18, no. 1, pp. 25–28, 2004. View at Publisher · View at Google Scholar · View at Scopus